British Business Bank commits €25m to EQT Life Sciences’ latest fund

British Business Bank has invested €25m ($28.6m) into task superior (VC) steadfast EQT Life Sciences' latest beingness sciences and medtech-dedicated fund.

Launched successful 2024 with a money size present totalling €216m, the EQT Health Economics 3 Fund (EQT HE3) is designed to enactment commercial-stage companies successful Europe processing aesculapian exertion and integer wellness technologies aimed astatine advancing healthcare delivery. Portfolio companies wrong the money see the UK's Cyted Health and Phagenesis.

The UK government's economical improvement bank's concern successful the Netherlands-based VC's latest money follows a €15m concern by Dutch promotional slope Invest-NL successful October 2025.

British Business Bank highlighted that its committedness to EQT HE3 represents the latest successful its ongoing efforts to enactment 'high potential' UK beingness sciences companies since the assemblage represents 1 of the 8 maturation areas portion of the UK's Industrial Strategy.

"The UK is location to a world-class beingness sciences sector, but scaling companies successful the assemblage requires specializer investors," Christine Hockley, managing manager and caput of commercialized equity funds astatine British Business Bank, explained.

"By investing successful high-quality planetary funds, we promote greater concern to travel backmost into the UK and guarantee UK companies payment from the superior and expertise of starring investors," Hockley continued.

EQT backs companies successful areas including aesculapian devices, wellness tech, and diagnostics development. With implicit €3.7bn crossed 13 backstage funds raised to date, the European beingness sciences capitalist has supported much than 150 companies from aboriginal objective improvement done to commercialisation. EQT has precocious backed companies including Galway, Ireland-headquartered rhinitis specializer Neurent Medical and Dutch insulin pump developer ViCentra.

British Business Bank's concern builds connected its erstwhile enactment with EQT, having co-invested successful the fund's portfolio companies' Phagenesis' $42m Series D financing circular successful 2023, and Cyted Health's $44m Series B circular successful September 2025.

Drew Burdon, spouse astatine EQT Life Sciences, commented: "Over caller years we person built an fantabulous narration with the slope done co-investments successful starring UK wellness tech companies. The bank's concern volition further lend to our committedness to pat into the charismatic UK wellness tech ecosystem and turn beardown companies together."

"British Business Bank commits €25m to EQT Life Sciences' latest fund" was primitively created and published by Medical Device Network, a GlobalData owned brand.